[Local use of a drug combination consisting of fluorouracil, cyclophosphamide and silicone sorbent in patients with colonic cancer].
Rustamov
I R
IR
Dzhulbekov
K I
KI
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy / Q000601:surgery; D000287:Administration, Topical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D011208:Powders; D012828:Silicones / Q000008:administration & dosage
D011208:Powders; D012828:Silicones; C078211:polymethylsiloxane; D003520:Cyclophosphamide; D005472:Fluorouracil
Mestnoe primenenie kompozitsii iz ftoruratsila, tsiklofosfana i kremiĭorganicheskogo sorbenta u bolńykh rakom tolstoĭ kishki.